Genome-wide association study identifies and validates genetic variation in the RIG-I/MAVS signaling pathway associated with HIV-related Kaposi sarcoma in children and adults - Top-Institutions - MDSpire

Genome-wide association study identifies and validates genetic variation in the RIG-I/MAVS signaling pathway associated with HIV-related Kaposi sarcoma in children and adults

  • By

  • Casey L. McAtee

  • Erin Peckham-Gregory

  • Pagna Sok

  • Melissa Richard

  • Luis Olivares

  • Deborah Marquez-Do

  • Grace Kisitu

  • Jeffrey Martin

  • Nader Kim El-Mallawany

  • Carl E. Allen

  • Joseph Lubega

  • Michael E. Scheurer

  • June 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Baylor College of Medicine Children’s Foundation – Uganda
    Baylor College of Medicine Children’s Foundation – Uganda

    Kampala, Uganda

    Key Differentiators

    • Infectious Disease

  • #2

    Avera Institute for Human Genetics
    Avera Institute for Human Genetics

    Sioux Falls, SD

    Key Differentiators

    • Genetics
    • Infectious Disease

  • #3

    Emory Primate Center
    Emory Primate Center

    Atlanta, GA

    Key Differentiators

    • Infectious Disease
    • Primate Research

Original Source(s)

Genome-wide association study identifies and validates genetic variation in the RIG-I/MAVS signaling pathway associated with HIV-related Kaposi sarcoma in children and adults

  • by Casey L. McAtee, Erin Peckham-Gregory, Pagna Sok, Melissa Richard, Luis Olivares, Deborah Marquez-Do, Grace Kisitu, Jeffrey Martin, Nader Kim El-Mallawany, Carl E. Allen, Joseph Lubega, Michael E. Scheurer

  • June 29, 2026

Related Content

Unmasking biomarkers in small cell lung cancer: implication for precision oncology

Case Report: Primary sporadic intramedullary malignant peripheral nerve sheath tumor with intracranial extension and a subpial nodule suggestive of early dissemination

Clinical evaluation of large language model recommendations in melanoma: comparison with multidisciplinary tumor board decisions in a real-world cohort